Good afternoon :)
US Stocks Collections

US Pharma Stocks: Leading US Pharma Companies in 2026

The US pharmaceutical market is one of the largest healthcare markets globally, estimated at over $550 bn in 2026. Driven by drug innovation, biotechnology advancements, ageing populations and rising demand for specialised therapies, US pharma stocks provide exposure to companies developing medicines across multiple therapeutic areas. This article explores US pharma stocks, their growth drivers, benefits, risks and key factors influencing their performance.

List of US Pharma Stocks in 2026

US Pharma Stocks

Explore US pharma stocks involved in pharmaceutical products. Analyse companies using live share price, market cap, returns, valuation, profitability and other key financial metrics.

Created by

@82600328260032

Showing 1 - 5 of 5 results

last updated at 8:30 AM IST 
NameUS Stocks (5)↓↓Sub-SectorSub-Sector↓↓Market CapMarket Cap↓↓Close PriceClose Price↓↓PE Ratio (TTM)PE Ratio (TTM)↓↓1M Return1M Return↓↓1D Return1D Return↓↓Return on EquityReturn on Equity↓↓PB RatioPB Ratio↓
1.High Tide IncHITIPharmaceutical RetailersPharmaceutical Retailers236.23236.232.662.66---3.80-3.80-1.67-1.67-26.04-26.043.233.23
2.PetMed Express IncPETSPharmaceutical RetailersPharmaceutical Retailers26.0126.011.181.18---24.84-24.84-0.50-0.50-78.56-78.561.461.46
3.POMDOCTOR+LIMITEDPOMPharmaceutical RetailersPharmaceutical Retailers6.166.162.032.03--154.07154.07-33.02-33.02----
4.Scienture Holdings, Inc.SCNXPharmaceutical RetailersPharmaceutical Retailers5.015.012.772.77---61.14-61.14-5.85-5.85-53.47-53.470.190.19
5.Ridgetech, Inc.RDGTPharmaceutical RetailersPharmaceutical Retailers3.023.020.840.84---9.24-9.24-1.87-1.87-3.55-3.550.080.08

Disclaimer: Please note that the above table is for informational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing. The data is derived from Tickertape Stock Screener and is subject to real-time updates.

Overviews of Top Pharmaceutical Companies

High Tide Inc

High Tide Inc is a cannabis-focused company operating retail stores, e-commerce platforms and cannabis accessory brands. The company serves consumers through its Canna Cabana retail network in Canada and focuses on expanding its membership-based retail model and integrated cannabis ecosystem.

PetMed Express Inc

PetMed Express Inc, also known as PetMeds, is an online pet pharmacy providing prescription and non-prescription medications, health products and supplies for pets. The company serves pet owners through digital platforms and focuses on convenient access to veterinary products.

Scienture Holdings, Inc.

Scienture Holdings is a pharmaceutical company focused on developing and commercialising healthcare products. The company works on prescription therapies across areas such as central nervous system disorders, women’s health and other specialty healthcare segments through its product pipeline.

POMDOCTOR LIMITED American Depositary Shares

POMDOCTOR Limited is a healthcare technology company focused on digital health solutions. The company provides platforms and services designed to improve patient engagement, healthcare access and wellness management through technology-enabled healthcare delivery models.

Wellgistics Health, Inc. Common Stock

Wellgistics Health is a healthcare technology and pharmaceutical services company focused on improving access to medications. The company operates through pharmacy networks, technology platforms and healthcare solutions designed to connect patients, providers and pharmacies.

What are Pharma US Stocks?

Pharma US stocks are shares of US-listed companies involved in developing, manufacturing and distributing medicines, vaccines and healthcare products. These companies operate across areas such as biotechnology, generic drugs, specialty therapies and medical research. Their performance is influenced by drug approvals, research pipelines, healthcare demand, pricing trends and regulatory developments.

How to Evaluate & Invest in US Pharma Company Stocks Using Tickertape?

One of the easiest ways to invest in Pharma US stocks from India is through a regulated platform like Tickertape. Here's how to invest in the US Pharma stock market from India, step by step.

    

  1. Create Your US Investing Account: Log in to Tickertape and head to US Stocks. Click on “Get Started” to begin the process.
  2. Select the Category and Sector: Select the ‘Pharmaceutical Retailers’ options under the ‘Healthcare’ sector, and sort through the Pharma sector stocks to select the one you want to invest in.
  3. Complete KYC: Complete your KYC verification digitally using DigiLocker or upload the required documents manually. The process typically takes 15 to 30 minutes.
  4. Connect Your Bank Account: Link your eligible bank account to initiate remittances under the Liberalised Remittance Scheme (LRS).
  5. Add Money to Your US Wallet: Transfer money from your bank account to your US Wallet. This can take up to 7 business days to reflect, depending on your bank.
  6. Make Your First Investment: Select the Pharma sector stock of your choice and start investing with as little as $1.

Taxation of US Pharma Stocks for Indian Investors

Indian investors in US pharma stocks are subject to tax rules in both India and the US. The tax treatment depends on factors such as capital gains, dividend income, holding period and applicable regulations. Understanding these rules helps investors evaluate the tax implications of investing in US-listed pharmaceutical companies.

Income / ActionHolding Period / ConditionTax Rate in the USTax Rate in India
Long-Term Capital Gains (LTCG)Held for > 24 months0% (Taxed only in India under DTAA)12.5% (+ applicable surcharge & cess)
Short-Term Capital Gains (STCG)Held for < 24 months0% (Taxed only in India under DTAA)Taxed as per your applicable income slab rate

Advantages of Investing in US Pharma Stocks

Large Healthcare Market

The US pharmaceutical market was valued at approximately $634 bn in 2024 and is projected to grow further, providing exposure to one of the world’s largest healthcare markets.

Innovation Exposure

US pharma stocks provide exposure to companies developing breakthrough treatments across areas such as cancer, diabetes, rare diseases and advanced biological therapies.

Recurring Demand

Medicines often address ongoing healthcare needs, allowing pharmaceutical companies to generate revenue through prescription demand, product portfolios and long-term treatment adoption.

Global Market Access

Large US pharmaceutical companies typically operate across international markets, allowing investors to gain exposure to global healthcare demand beyond domestic US sales.

Pipeline Growth Potential

Pharmaceutical valuations are often influenced by upcoming drug launches, clinical trial results and regulatory approvals, which can create new revenue opportunities.

Install the Tickertape app and enjoy a more hands-on investing experience
  • portfolio-iconReceive real-time market alerts for timely decisions
  • portfolio-iconMonitor your portfolio from the palm of your hands
  • portfolio-iconWatchlist stocks and mutual funds to stay updated

Risks of Investing in US Pharma Stocks

Clinical Trial Failure

Drug development involves significant uncertainty, as only a small percentage of drug candidates entering clinical trials eventually receive approval.

Patent Expiry

Loss of patent protection can expose branded drugs to generic competition, reducing revenue from established products and affecting company growth.

Regulatory Risks

FDA approvals, pricing regulations and compliance requirements can influence drug launches, operating costs and future revenue expectations.

Pricing Pressure

Government policies, insurance negotiations and competition from generics can impact pharmaceutical companies’ ability to maintain drug pricing and margins.

Research Costs

Developing new medicines requires substantial R&D spending, with costs often reaching billions of dollars before a product reaches the market.

Factors to Consider Before Investing in US Pharma Stocks

Drug Approvals

FDA approvals can significantly impact pharma companies by determining whether new therapies can reach patients and generate future revenue streams.

Pipeline Strength

The quality and diversity of a company’s drug pipeline influence its ability to replace ageing products and sustain long-term growth.

Revenue Mix

Exposure across branded drugs, generics, specialty medicines and biologics affects a company’s growth profile and sensitivity to market changes.

R&D Efficiency

Companies that convert research spending into successful drug launches may achieve better profitability and maintain competitive advantages.

Pricing Trends

Changes in drug pricing, reimbursement policies and healthcare spending patterns can directly affect pharmaceutical revenues and margins.

Patent Portfolio

The timing of patent expiries and the strength of intellectual property protection influence revenue stability for major pharmaceutical products.

Key Growth Drivers for US Pharma Stocks

Innovation Pipeline

US pharma companies continue investing in novel therapies, with areas such as oncology, obesity drugs, gene therapy and immunology driving future growth opportunities.

GLP-1 Demand

Weight-loss and diabetes medicines such as GLP-1 therapies have become major growth drivers, with rising adoption supporting revenue expansion for companies developing metabolic treatments.

Biotech Advancements

Advances in biologics, personalised medicine and AI-assisted drug discovery are helping pharmaceutical companies develop targeted treatments for complex diseases and improve research efficiency.

Ageing Population

An ageing US population and rising prevalence of chronic diseases continue increasing demand for medicines across cardiovascular, oncology, neurological and specialty healthcare segments.

Manufacturing Expansion

US pharmaceutical companies are increasing domestic manufacturing investments, with major drugmakers announcing hundreds of billions of dollars in planned R&D and production capacity expansion.

How to Track US Pharma Stocks From India on Tickertape?

You can track US Pharma stocks and ETFs from India on Tickertape’s US Stocks & ETFs platform.

  1. Log in: Visit Tickertape and sign in to your account.
  2. Search for the sector: Look up for the “Pharmaceutical Retailers” sector.
  3. Use the screener: Filter US stocks or ETFs by Pharma or related sectors.
  4. Compare metrics: Review live price, market cap, performance, valuation ratios, risk labels, financials, and ETF holdings.
  5. Create a watchlist: Add selected Pharma stocks and ETFs to track them over time.

Conclusion

US pharma stocks represent companies involved in developing and commercialising medicines across areas such as biotechnology, specialty therapies and healthcare innovation. Their performance depends on factors including drug approvals, research pipelines, pricing trends, regulatory changes and market demand. Investors can use the Tickertape US Stock Screener with 60+ filters to compare pharma companies based on financial metrics, valuations, profitability, growth indicators and other parameters before conducting further research.

Frequently Asked Questions on US Pharma Stocks

  1. What are US Pharma Stocks?

    US pharma stocks are shares of companies listed on US exchanges that develop, manufacture and distribute medicines, vaccines and healthcare therapies. These pharmaceutical stocks include large drug manufacturers, biotechnology firms and specialty healthcare companies operating across the global pharmaceutical market.

  2. Which are the top companies are included in US Pharma Stocks?

    The following are the best US pharma stocks based on 1M returns as of 12th August, 2026:

    1. Scienture Holdings, Inc.
    2. Wellgistics Health, Inc. Common Stock
    3. High Tide Inc
    4. PetMed Express Inc
    Disclaimer: Please note that the above US Pharma stocks list is for educational purposes only, and is not recommendatory. Please conduct your own research or consult with your financial advisor before investing.

  3. What is the outlook for US Pharma Stocks in 2026?

    The outlook for US pharma stocks in 2026 is shaped by drug innovation, biotechnology advancements, GLP-1 therapies, AI-driven research and healthcare demand. The US pharmaceutical market is projected to continue growing, supported by new therapies and rising healthcare spending. Disclaimer: Market outlooks can change due to economic conditions, regulations and company-specific factors. This information is for educational purposes only and should not be considered investment advice.

  4. Are Pharma US Stocks considered risky for Indian investors?

    Pharma US stocks can involve risks related to clinical trial outcomes, regulatory approvals, patent expiries, pricing pressure and currency movements. Indian investors should also consider taxation and foreign exchange factors when analysing a pharma stocks list. Disclaimer: Risk levels vary across companies and depend on individual financial circumstances. Investors should conduct their own research before making investment decisions.

  5. What is the difference between individual US Pharma stocks and Pharma-focused ETFs?

    Individual US pharma stocks provide exposure to a specific company and its drug pipeline, financial performance and research outcomes. Pharma-focused ETFs hold a basket of companies, offering broader exposure to the sector, including companies tracked by a US pharma index.

  6. How can I compare US Pharma Stocks on Tickertape?

    Investors can use the Tickertape US Stock Screener to compare US pharma stocks using financial metrics, valuation parameters, profitability data, growth indicators and other available filters. This can help analyse companies and compare them with peers across the us pharma stock index.

  7. Can beginners invest in US Pharma Stocks?

    Beginners can invest in US pharma stocks through platforms that provide access to US-listed securities. Before investing, beginners should understand drug development cycles, regulatory risks, company financials and factors affecting pharmaceutical stocks. Disclaimer:Whether an investment is suitable depends on an investor’s financial goals, risk appetite and research. This content is for educational purposes only.

  8. How to invest in US Pharma Stocks?

    Investors can invest in US Pharma stocks from India through a regulated platform like Tickertape. The process generally involves:

    1. Create a US investing account: Log in to Tickertape, visit the US Stocks section and start the account-opening process.
    2. Select Pharma stocks: Explore Pharma-related companies and compare available stocks.
    3. Complete KYC: Complete digital verification using DigiLocker or submit the required documents.
    4. Connect your bank account: Link an eligible bank account for remittances under the Liberalised Remittance Scheme (LRS).
    5. Add funds: Transfer money to your US investing account.
    6. Invest: Select a Pharma stock and place an order. Some platforms may allow fractional investing from $1.

  9. What metrics are commonly used to evaluate US Pharma Stocks?

    Common metrics used to evaluate US pharma stocks include revenue growth, profit margins, R&D spending, drug pipeline strength, FDA approvals, patent expiry timelines, valuation ratios and cash flow. These metrics help assess the financial position and growth potential of companies included in a US pharma stocks list. Disclaimer: The metrics mentioned are for educational purposes only and do not indicate the quality or suitability of any stock. Investors should evaluate companies based on their individual financial goals and risk profile.

  10. Do US Pharma stocks pay dividends?

    Some established US pharma companies pay dividends, although dividend payments depend on earnings, cash flows and company policies. Investors analysing pharmaceutical stocks can review dividend yield, payout ratios and dividend history to understand a company’s approach to returning capital to shareholders. Disclaimer: Dividend payments are not guaranteed and may change based on company decisions and market conditions. Past dividend history does not indicate future dividend payments.